Opportunistic Infections
Information
- Disease name
- Opportunistic Infections
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00814827 | Active, not recruiting | Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma | January 7, 2010 | ||
| NCT05694546 | Active, not recruiting | N/A | Re-engagement at Discharge 2 | August 8, 2023 | July 31, 2024 |
| NCT01557803 | Completed | Prediction and Pathogenesis of the Immune Reconstitution Inflammatory Syndrome | January 2012 | January 2015 | |
| NCT02337595 | Completed | Phase 1/Phase 2 | Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation | August 2014 | January 2016 |
| NCT02942173 | Completed | Phase 2/Phase 3 | CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT | October 2016 | August 21, 2020 |
| NCT00137657 | Completed | Phase 4 | Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance | February 2002 | November 2003 |
| NCT00001477 | Completed | Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy | August 1995 | October 2000 | |
| NCT03083756 | Completed | Validation of a Risk Score Opportunistic Infections Development in Kidney Transplant Patients | August 2014 | February 15, 2017 | |
| NCT03087890 | Completed | Phase 4 | Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria | March 30, 2017 | July 25, 2019 |
| NCT05349383 | Completed | Evaluation of Reporting of Antibody-Drug Conjugate Associated Sepsis-related Toxicities | April 22, 2022 | June 1, 2022 | |
| NCT02454569 | Recruiting | Vicente Ferrer HIV Cohort Study | September 2009 | January 2040 | |
| NCT02982902 | Recruiting | Early Phase 1 | T Cell Therapy of Opportunistic Cytomegalovirus Infection | May 27, 2020 | September 2025 |
| NCT03798301 | Recruiting | Phase 1 | Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells | February 6, 2020 | September 2026 |
| NCT01541631 | Unknown status | N/A | A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes | May 2012 | June 2013 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D009894